These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
359 related articles for article (PubMed ID: 33959755)
1. The Cholesterol Metabolite 27HC Increases Secretion of Extracellular Vesicles Which Promote Breast Cancer Progression. Baek AE; Krawczynska N; Das Gupta A; Dvoretskiy SV; You S; Park J; Deng YH; Sorrells JE; Smith BP; Ma L; Nelson AT; McDowell HB; Sprenger A; Henn MA; Madak-Erdogan Z; Kong H; Boppart SA; Boppart MD; Nelson ER Endocrinology; 2021 Jul; 162(7):. PubMed ID: 33959755 [TBL] [Abstract][Full Text] [Related]
2. 27-Hydroxycholesterol acts on myeloid immune cells to induce T cell dysfunction, promoting breast cancer progression. Ma L; Wang L; Nelson AT; Han C; He S; Henn MA; Menon K; Chen JJ; Baek AE; Vardanyan A; Shahoei SH; Park S; Shapiro DJ; Nanjappa SG; Nelson ER Cancer Lett; 2020 Nov; 493():266-283. PubMed ID: 32861706 [TBL] [Abstract][Full Text] [Related]
3. 27-Hydroxycholesterol Enhances Secretion of Extracellular Vesicles by ROS-Induced Dysregulation of Lysosomes. Das Gupta A; Park J; Sorrells JE; Kim H; Krawczynska N; Pradeep D; Wang Y; Vidana Gamage HE; Nelczyk AT; Boppart SA; Boppart MD; Nelson ER Endocrinology; 2024 Sep; 165(11):. PubMed ID: 39298675 [TBL] [Abstract][Full Text] [Related]
4. The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells. Baek AE; Yu YA; He S; Wardell SE; Chang CY; Kwon S; Pillai RV; McDowell HB; Thompson JW; Dubois LG; Sullivan PM; Kemper JK; Gunn MD; McDonnell DP; Nelson ER Nat Commun; 2017 Oct; 8(1):864. PubMed ID: 29021522 [TBL] [Abstract][Full Text] [Related]
5. Cholesterol Metabolite 27-Hydroxycholesterol Enhances the Secretion of Cancer Promoting Extracellular Vesicles by a Mitochondrial ROS-Induced Impairment of Lysosomal Function. Das Gupta A; Park J; Sorrells JE; Kim H; Krawczynska N; Gamage HEV; Nelczyk AT; Boppart SA; Boppart MD; Nelson ER bioRxiv; 2024 May; ():. PubMed ID: 38746134 [TBL] [Abstract][Full Text] [Related]
6. The cholesterol metabolite 27-hydroxycholesterol promotes atherosclerosis via proinflammatory processes mediated by estrogen receptor alpha. Umetani M; Ghosh P; Ishikawa T; Umetani J; Ahmed M; Mineo C; Shaul PW Cell Metab; 2014 Jul; 20(1):172-82. PubMed ID: 24954418 [TBL] [Abstract][Full Text] [Related]
8. 27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology. Nelson ER; Wardell SE; Jasper JS; Park S; Suchindran S; Howe MK; Carver NJ; Pillai RV; Sullivan PM; Sondhi V; Umetani M; Geradts J; McDonnell DP Science; 2013 Nov; 342(6162):1094-8. PubMed ID: 24288332 [TBL] [Abstract][Full Text] [Related]
9. Host CYP27A1 expression is essential for ovarian cancer progression. He S; Ma L; Baek AE; Vardanyan A; Vembar V; Chen JJ; Nelson AT; Burdette JE; Nelson ER Endocr Relat Cancer; 2019 Jul; 26(7):659-675. PubMed ID: 31048561 [TBL] [Abstract][Full Text] [Related]
10. The impact of 27-hydroxycholesterol on endometrial cancer proliferation. Gibson DA; Collins F; Cousins FL; Esnal Zufiaurre A; Saunders PTK Endocr Relat Cancer; 2018 Apr; 25(4):381-391. PubMed ID: 29371332 [TBL] [Abstract][Full Text] [Related]
11. Our evolving understanding of how 27-hydroxycholesterol influences cancer. Ma L; Cho W; Nelson ER Biochem Pharmacol; 2022 Feb; 196():114621. PubMed ID: 34043965 [TBL] [Abstract][Full Text] [Related]
12. Impact of 27-hydroxylase (CYP27A1) and 27-hydroxycholesterol in breast cancer. Kimbung S; Chang CY; Bendahl PO; Dubois L; Thompson JW; McDonnell DP; Borgquist S Endocr Relat Cancer; 2017 Jul; 24(7):339-349. PubMed ID: 28442559 [TBL] [Abstract][Full Text] [Related]
14. Neutrophils exposed to a cholesterol metabolite secrete extracellular vesicles that promote epithelial-mesenchymal transition and stemness in breast cancer cells. Krawczynska N; Wang Y; Lim K; Das Gupta A; Lenczowski A; Abughazaleh M; Bendre SV; Kockaya LI; Schane CP; Fei Y; Hernandez AG; Drnevich J; Chan J; Dobrucki LW; Boppart MD; Ostrander J; Nelson ER bioRxiv; 2024 Aug; ():. PubMed ID: 39131340 [TBL] [Abstract][Full Text] [Related]
15. The endogenous selective estrogen receptor modulator 27-hydroxycholesterol is a negative regulator of bone homeostasis. DuSell CD; Nelson ER; Wang X; Abdo J; Mödder UI; Umetani M; Gesty-Palmer D; Javitt NB; Khosla S; McDonnell DP Endocrinology; 2010 Aug; 151(8):3675-85. PubMed ID: 20501668 [TBL] [Abstract][Full Text] [Related]
16. 27-Hydroxycholesterol Binds GPER and Induces Progression of Estrogen Receptor-Negative Breast Cancer. Avena P; Casaburi I; Zavaglia L; Nocito MC; La Padula D; Rago V; Dong J; Thomas P; Mineo C; Sirianni R; Shaul PW Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326671 [TBL] [Abstract][Full Text] [Related]
17. Estrogen Receptor Beta-Mediated Modulation of Lung Cancer Cell Proliferation by 27-Hydroxycholesterol. Hiramitsu S; Ishikawa T; Lee WR; Khan T; Crumbley C; Khwaja N; Zamanian F; Asghari A; Sen M; Zhang Y; Hawse JR; Minna JD; Umetani M Front Endocrinol (Lausanne); 2018; 9():470. PubMed ID: 30190703 [TBL] [Abstract][Full Text] [Related]
18. Role of reactive oxygen species in regulating 27-hydroxycholesterol-induced apoptosis of hematopoietic progenitor cells and myeloid cell lines. Woo SY; Lee H; Park SM; Choi HS; Kim J; Kwon M; Sohn J; Nam JH; Kim HS; Song P; Baryawno N; Kim YH; Kim K; Lee D Cell Death Dis; 2022 Oct; 13(10):916. PubMed ID: 36316327 [TBL] [Abstract][Full Text] [Related]
19. Sex-opposed inflammatory effects of 27-hydroxycholesterol are mediated via differences in estrogen signaling. Houben T; Bitorina AV; Oligschlaeger Y; Jeurissen ML; Rensen S; Köhler SE; Westerterp M; Lütjohann D; Theys J; Romano A; Plat J; Shiri-Sverdlov R J Pathol; 2020 Aug; 251(4):429-439. PubMed ID: 32472585 [TBL] [Abstract][Full Text] [Related]
20. Cholesterol and breast cancer pathophysiology. Nelson ER; Chang CY; McDonnell DP Trends Endocrinol Metab; 2014 Dec; 25(12):649-55. PubMed ID: 25458418 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]